Prior high‐risk <scp>HPV</scp> testing and <scp>P</scp>ap test results for 427 invasive cervical cancers in China's largest <scp>CAP</scp>‐certified laboratory

Abstract

These data demonstrate a considerable prior hrHPV-negative rate and a lower prior Pap-negative rate in patients with invasive cervical carcinoma (especially adenocarcinoma) from a population of women without access to an established screening program.